ChemicalBook >> CAS DataBase List >>Antitumor?agent-109

Antitumor?agent-109

Antitumor?agent-109 structure

CAS No.: 3052354-70-5

Chemical Name:: Antitumor?agent-109

Synonyms: Antitumor?agent-109;5-Bromo-2-(3,4,5-trimethoxybenzyl)-1,2,3,4-tetrahydroisoquinoline

CBNumber:: CB313695250

Molecular Formula:

Molecular Weight:: 0

MDL Number:

MOL File:: Mol file

MSDS File:: SDS

Last updated:2025-04-18 09:52:01

Request For Quotation

Antitumor?agent-109 Properties

form	Solid
color	White to off-white

Antitumor?agent-109 price

Manufacturer	Product number	Product description	CAS number	Packaging	Price	Updated	Buy
ChemScene	CS-0880980	HA-CD44 interaction inhibitor 1 99.34%	3052354-70-5	5mg	$276	2026-06-04	Buy
ChemScene	CS-0880980	HA-CD44 interaction inhibitor 1 99.34%	3052354-70-5	10mg	$417	2026-06-04	Buy
ChemScene	CS-0880980	HA-CD44 interaction inhibitor 1 99.34%	3052354-70-5	25mg	$751	2026-06-04	Buy
ChemScene	CS-0880980	HA-CD44 interaction inhibitor 1 99.34%	3052354-70-5	50mg	$1127	2026-06-04	Buy
ChemScene	CS-0880980	HA-CD44 interaction inhibitor 1 99.34%	3052354-70-5	100mg	$1690	2026-06-04	Buy

Product number	Packaging	Price	Buy
CS-0880980	5mg	$276	Buy
CS-0880980	10mg	$417	Buy
CS-0880980	25mg	$751	Buy
CS-0880980	50mg	$1127	Buy
CS-0880980	100mg	$1690	Buy

Antitumor?agent-109 Chemical Properties,Uses,Production

Uses

Antitumor agent-109 (compound 6) is an inhibitor of hyaluronic acid (HY-B0633A) targeting to CD44, as well as an anti-tumor agent. Hyaluronic acid interacts with differentiation cluster 44 (CD44) and is involved in tumor growth and invasion. Antitumor agent-109 inhibits MDA-MB-231 cells with EC50 value of 0.59 μM[1].

References

[1] Espejo-Román JM, et al. N-aryltetrahydroisoquinoline derivatives as HA-CD44 interaction inhibitors: Design, synthesis, computational studies, and antitumor effect. Eur J Med Chem. 2023 Oct 5;258:115570. DOI:10.1016/j.ejmech.2023.115570

Antitumor?agent-109 Preparation Products And Raw materials

Raw materials

Preparation Products

Antitumor?agent-109 Suppliers

Global( 9)Suppliers

Supplier	Tel	Email	Country	ProdList	Advantage
Tianjin Kailiqi Biotechnology Co., Ltd.	15076683720	klq@cw-bio.com	China	9796	55
Shanghai Chaolan Chemical Technology Center	QQ：65489617 13301690235	Sales@ATKchemical.com	China	9699	58
Jinan Jiuli Biotechnology Co. , Ltd.	15865264761	486064515@qq.com	China	4960	58
Shaoguan Qicheng Biotechnology Co., Ltd	18122215013	780229652@qq.com	China	1392	58
Jiangsu Aikon Biopharmaceutical R&D Co.,Ltd	025-5885952 15955137747	sales@aikonchem.com	China	8012	58
TargetMol	400-821-0310 15002144251	xuexiang.shao@tsbiochem.com	China	29128	58
Zhejiang Huida Biotech Co., Ltd.	0571-89903022 18679456698	zilong@hizyme.com	China	7853	58
ATK CHEMICAL COMPANY LIMITED	+undefined-21-51877795	ivan@atkchemical.com	China	32997	60

Supplier	Advantage
Tianjin Kailiqi Biotechnology Co., Ltd.	55
Shanghai Chaolan Chemical Technology Center	58
Jinan Jiuli Biotechnology Co. , Ltd.	58
Shaoguan Qicheng Biotechnology Co., Ltd	58
Jiangsu Aikon Biopharmaceutical R&D Co.,Ltd	58
TargetMol	58
Zhejiang Huida Biotech Co., Ltd.	58
ATK CHEMICAL COMPANY LIMITED	60

3052354-70-5(Antitumor?agent-109)Related Search:

Vandortuzumab Vedotin VJDT Anti-cancer compound library Tinurilimab Polatuzumab vedotin

Lirilumab

1of2

Antitumor?agent-109 5-Bromo-2-(3,4,5-trimethoxybenzyl)-1,2,3,4-tetrahydroisoquinoline 3052354-70-5